COVID-19 & CancerFree Pandemic: Bracing for coronavirus surge March 13, 2020Vol.46 No.11By Alexandria Carolan and Matthew Bin Han Ong
COVID-19 & CancerFreeGuest Editorial COVID-19 and the cancer patient: A call to action for balancing cancer care and viral risk March 13, 2020Vol.46 No.11By Karen E. Knudsen and Roy A. Jensen
Conversation with The Cancer LetterCOVID-19 & CancerFree What to expect: Oncology’s response to coronavirus in Italy"It's like being in a war" March 11, 2020Vol.46 No.11By Alexandria Carolan
Clara Bloomfield, blood cancer expert and destroyer of glass ceilings, dies at 77 March 06, 2020Vol.46 No.10By Electra D. Paskett
Moffitt execs were made aware of Howard McLeod’s China activities, ousted researcher’s attorney says March 06, 2020Vol.46 No.10By Matthew Bin Han Ong
COVID-19 & CancerFree Coronavirus vs. oncology: Meeting cancellations, travel restrictions, fears about drug supply chain March 04, 2020Vol.46 No.10By Alexandria Carolan
FDA approved 11 new agents, 30 supplemental indications in cancer in 2019 February 28, 2020Vol.46 No.09By Alexandria Carolan
ODAC: Thumbs up for Eli Lilly’s Cyramza, thumbs down for STEBA’s Tookad February 28, 2020Vol.46 No.09By Paul Goldberg
Trials & Tribulations Lung cancer: Significant progress leads to record annual decrease in cancer mortality February 21, 2020Vol.46 No.08By Fred R. Hirsch
